相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
Thomas J. Scriba et al.
LANCET INFECTIOUS DISEASES (2021)
Tuberculosis - United States, 2020
Molly Deutsch-Feldman et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis
Jorge R. Ledesma et al.
BMC INFECTIOUS DISEASES (2021)
Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs
Lisa A. Ronald et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis
Jonathon R. Campbell et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
S. Swindells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The global prevalence of latent tuberculosis: a systematic review and meta-analysis
Adam Cohen et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis
Giovanni Sotgiu et al.
JOURNAL OF INFECTION (2019)
Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons
Amita Gupta et al.
PLOS MEDICINE (2019)
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
D. R. Tait et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection
Paul K. Drain et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Prevention of M-tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
E. Nemes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
D. Menzies et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
David M. Lewinsohn et al.
CLINICAL INFECTIOUS DISEASES (2017)
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial
Anani Badje et al.
LANCET GLOBAL HEALTH (2017)
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection A Randomized Trial
Robert Belknap et al.
ANNALS OF INTERNAL MEDICINE (2017)
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons
Timothy R. Sterling et al.
AIDS (2016)
Screening for Latent Tuberculosis Infection in Adults US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?
Niaz Banaei et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study
Timothy R. Sterling et al.
CLINICAL INFECTIOUS DISEASES (2015)
Latent Mycobacterium tuberculosis Infection
Haileyesus Getahun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Treatment for Preventing Tuberculosis in Children and Adolescents A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid
M. Elsa Villarino et al.
JAMA PEDIATRICS (2015)
Interferon-γ Release Assays and Tuberculin Skin Testing for Diagnosis of Latent Tuberculosis Infection in Healthcare Workers in the United States
Susan E. Dorman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Madhukar Pai et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Interferon-γ Release Assays for the Diagnosis of Tuberculosis and Tuberculosis Infection in HIV-Infected Adults: A Systematic Review and Meta-Analysis
Miguel Santin et al.
PLOS ONE (2012)
Interferon-Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Individuals: A Systematic Review and Meta-Analysis
Adithya Cattamanchi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Latent Tuberculosis Infection in the United States
C. Robert Horsburgh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
New Regimens to Prevent Tuberculosis in Adults with HIV Infection
Neil A. Martinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Timothy R. Sterling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Latent TB Infection Treatment Acceptance and Completion in the United States and Canada
C. Robert Horsburgh et al.
CHEST (2010)
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Clifton E. Barry et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update
Madhukar Pai et al.
ANNALS OF INTERNAL MEDICINE (2008)
Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin
Alfred Lardizabal et al.
CHEST (2006)
Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis - A retrospective study
Kathleen R. Page et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: A meta-analysis
J Ena et al.
CLINICAL INFECTIOUS DISEASES (2005)
分享论文
